Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Recovery 1Prostatic Neoplasms 1Lung Neoplasms 1

Interventions

Early Intervention, Educational 29Educational Status 28Blood Specimen Collection 28Standard of Care 26Methods 24Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Surveys and Questionnaires 17Practice Guidelines as Topic 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Biopsy 11Specimen Handling 10Interviews as Topic 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6Breathing Exercises 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Powders × Clear all
NCT05631028 2023-03-14

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Shanghai Pulmonary Hospital, Shanghai, China

Phase NA Completed
115 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡